Researchers find controlling element of Huntington's disease
A three molecule complex may be a target for treating Huntington's disease, a genetic disorder affecting the brain. This finding by an international research team including scientists from the German Center for Neurodegenerative ...
Diseases, Conditions, Syndromes
Feb 26, 2013 |
5 / 5 (2) |
0
|
AAN: New guideline on how to best treat involuntary movements in Huntington's disease
A new guideline released by the American Academy of Neurology recommends several treatments for people with Huntington's disease who experience chorea—jerky, random, uncontrollable movements that can make everyday activities ...
Neuroscience
Jul 18, 2012 |
not rated yet |
0
Two proteins offer a 'clearer' way to treat Huntington's disease
In a paper published in the July 11 online issue of Science Translational Medicine, researchers at the University of California, San Diego School of Medicine have identified two key regulatory proteins critic ...
Neuroscience
Jul 11, 2012 |
4.8 / 5 (4) |
0
|
Speeding up Huntington's research
(Medical Xpress) -- Human brain cells showing aspects of Huntington’s Disease have been developed, opening up new research pathways for treating the fatal disorder.
Neuroscience
Jul 09, 2012 |
5 / 5 (1) |
0
Scientists correct Huntington's disease mutation in induced pluripotent stem cells
Johns Hopkins researchers, working with an international consortium, say they have generated stem cells from skin cells from a person with a severe, early-onset form of Huntington's disease (HD), and turned them into neurons ...
Medical research
Jun 28, 2012 |
5 / 5 (2) |
0
|
Proposed drug may reverse Huntington's disease symptoms
With a single drug treatment, researchers at the Ludwig Institute for Cancer Research at the University of California, San Diego School of Medicine can silence the mutated gene responsible for Huntington's ...
Neuroscience
Jun 20, 2012 |
not rated yet |
0
|
Device implanted in brain has therapeutic potential for Huntington's disease
Studies suggest that neurotrophic factors, which play a role in the development and survival of neurons, have significant therapeutic and restorative potential for neurologic diseases such as Huntington's ...
Neuroscience
Jun 18, 2012 |
not rated yet |
0
|
Reach2HD, a Phase II study in Huntington's disease, launched
The Huntington Study Group (HSG), under the leadership of Ray Dorsey, M.D. with Johns Hopkins Medical and Diana Rosas, M.D. with Massachusetts General Hospital, is conducting a clinical trial in Huntington's disease (HD) ...
Neuroscience
Jun 07, 2012 |
not rated yet |
0
Researchers restore neuron function to brains damaged by Huntington's disease
Researchers from South Korea, Sweden, and the United States have collaborated on a project to restore neuron function to parts of the brain damaged by Huntington's disease (HD) by successfully transplanting HD-induced pluripotent ...
Neuroscience
May 29, 2012 |
5 / 5 (1) |
0
Having Huntington's disease or other 'polyQ' diseases protects against cancer, suggesting common genetic mechanism
Having Huntington's disease or other diseases known as polyglutamine (polyQ) diseases reduces a person's risk of getting cancer, suggesting a common genetic mechanism, concludes an Article published Online First by The Lancet On ...
Cancer
Apr 11, 2012 |
not rated yet |
0
Health and happiness: Measuring wellbeing in Huntington’s disease
(Medical Xpress) -- Scientists at the University of Reading have designed a new tool which could significantly aid research and management of an incurable brain disease affecting thousands of people.
Diseases, Conditions, Syndromes
Mar 09, 2012 |
not rated yet |
0
Observations refute widely held view on causal mechanism in amyotrophic lateral sclerosis
In science, refuting a hypothesis can be as significant as proving one, all the more so in research aimed at elucidating how diseases proceed with a view toward preventing, treating, or curing them. Such a ...
Diseases, Conditions, Syndromes
Feb 29, 2012 |
not rated yet |
0
|
New knowledge on the pharmacology of dopamine stabilizers
A study from Karolinska Institutet in Sweden shows that a new drug for Huntington's disease – pridopidine or dopamine stabiliser ACR16 – might operate via previously unknown mechanisms of action. Researchers have ...
Psychology & Psychiatry
Feb 24, 2012 |
not rated yet |
0
New discovery in fight against Huntington's disease
Researchers at National University of Ireland Galway have made a significant scientific discovery in the fight against Huntington's disease. The novel findings are published 21 February in the online, open access journal ...
Parkinson's & Movement disorders
Feb 21, 2012 |
5 / 5 (2) |
0
|
Investigators achieve important step toward treating Huntington's disease
A team of researchers at the UC Davis Institute for Regenerative Cures has developed a technique for using stem cells to deliver therapy that specifically targets the genetic abnormality found in Huntington's disease, a hereditary ...
Neuroscience
Jan 19, 2012 |
not rated yet |
0
|
